Ondine Biomedical (LSE:OBI) Other Current Liabilities : £0.91 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ondine Biomedical Other Current Liabilities?

Ondine Biomedical's other current liabilities for the quarter that ended in Jun. 2024 was £0.91 Mil.

Ondine Biomedical's quarterly other current liabilities increased from Jun. 2023 (£0.91 Mil) to Dec. 2023 (£0.95 Mil) but then declined from Dec. 2023 (£0.95 Mil) to Jun. 2024 (£0.91 Mil).

Ondine Biomedical's annual other current liabilities increased from Dec. 2021 (£0.33 Mil) to Dec. 2022 (£0.67 Mil) and increased from Dec. 2022 (£0.67 Mil) to Dec. 2023 (£0.95 Mil).

Ondine Biomedical Other Current Liabilities Historical Data

The historical data trend for Ondine Biomedical's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ondine Biomedical Other Current Liabilities Chart

Ondine Biomedical Annual Data

Trend

Dec08

Dec09

Dec10

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Ondine Biomedical Semi-Annual Data
	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Ondine Biomedical Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Ondine Biomedical Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Ondine Biomedical's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ondine Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ondine Biomedical Inc (LSE:OBI) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

OBIMF:USA VF5:Germany

Address

1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6

Website

https://www.ondinebio.com

Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.

Ondine Biomedical Headlines

No Headlines